Featured news from NHIVNA
HIV-related news from NAM
In the era of universal treatment, what are HIV clinical guidelines for?
Gus Cairns, 2016-12-22 10:20:00
The purpose and structure of clinical HIV guidelines may have to change radically now
that universal treatment on diagnosis is the clinical consensus, physicians
from the European AIDS Clinical Society (EACS) heard in a meeting on standards
of care last month in Brussels. A scene-setting presentation by Kevin de Cock of
the US Centers for Disease Control (CDC) has already been summarised in
“We have to get political” was how Manual Battegay, outgoing
president of EACS, summed it up.
He explained that in an era of "test-and-treat", “getting to
zero” and the UNAIDS 90-90-90 target, which seeks to have 72% of everyone with
HIV virally undetectable by 2020 and 86% by 2030, HIV treatment has moved from
an individualised patient-care model, like cancer treatment, towards a public
health model, like vaccination or TB treatment.
This implied that a professional body like EACS had to ally
itself to other organisations and issue guidelines in collaboration with normative
agencies like the World Health Organization (WHO) and surveillance ones like the
European Centre for Disease Control (ECDC).